Search clinical trials for: Empagliflozin low placebo

Total 60916 results

China Medical University Hospital

Recruiting

Low Level Laser Therapy Applied in Orthodontic Tooth Movement

Orthodontic Appliance Complication

Taiwan
Cairo University

Completed

Donor Site Healing Response to Low Level Laser Therapy Following Skin Graft Surgery

Skin Graft

Egypt
Boehringer Ingelheim

Completed

4 Week Treatment With Three Oral Doses of BI 10773 in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Germany
University of Virginia

Recruiting

Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease (SMILE)

Myocardial Ischemia

United States
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults (MUCILA)

Mucositis Oral

France
Warren Bishop

Completed

Fiber Health Benefits

Healthy

United States
Chang Gung Memorial Hospital

Completed

Low Energy Shock Wave for the Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

Interstitial Cystitis

Taiwan
University of Nove de Julho

Completed

Low Level Laser Therapy to Reduce Comorbidity in Spinal Surgery (LASPINE)

Failed Back Surgery Syndrome

Brazil
Eugonia
Aristotle University Of Thessaloniki

Completed

Comparison of 2 Different Flow Rates During Oocyte Retrieval

Infertility

Greece
Belfast Health and Social Care Trust

Recruiting

High VS Low Flow Nasal O2 for Acute Hypercapnic Respiratory Failure

Acute Hypercapnic Respiratory Failure | Acute Exacerbation of COPD

United Kingdom
University of Texas Southwestern Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging

Obesity, Visceral

United States
Virginia Commonwealth University

Completed

Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis

Cystic Fibrosis

United States
Ann & Robert H Lurie Children's Hospital of Chicago

Not yet recruiting

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease (SHIELD)

Non-Alcoholic Fatty Liver Disease
Federal University of Health Science of Porto Alegre

Completed

Phototherapy in Association to Resistance Training in the Elderly: the Effect on Muscle Strength, Muscle Mass and Functional Capacity

Elderly Men

Brazil
G.Gennimatas General Hospital
2nd Department of Cardiology, "Attikon" University Hospital, National and...

Not yet recruiting

Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention

Acute Kidney Injury | Percutaneous Coronary Intervention | Left Cardiac Catheterization | Sodium-glucose Co-transporter 2 Inhibitors

Greece
University of Washington
AstraZeneca

Completed

Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2

Myocardial Fibrosis | Type 2 Diabetes Mellitus | Myocardial Inflammation

United States
Hospices Civils de Lyon

Withdrawn

Acute Reno-Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List (ARCADIA-HF)

End-stage Heart Failure

France
AstraZeneca
Bristol-Myers Squibb

Completed

Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 2)

Type 1 Diabetes Mellitus

United States, Germany, Belgium, Canada, Japan, Chile, United Kingdom, Poland, Netherlands, Argentina, Sweden, Russian Federation, Switzerland
EMS

Not yet recruiting

Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia

Type 2 Diabetes Mellitus | Dyslipidemia
AstraZeneca

Terminated

Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin

Type 2 Diabetes Mellitus

Thailand, Vietnam
University of Dundee
British Heart Foundation

Completed

SGLT2 Inhibition in Combination With Diuretics in Heart Failure (RECEDE-CHF)

Heart Failure | Type 2 Diabetes Mellitus

United Kingdom
Medical University of Vienna

Recruiting

Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction

Reperfusion Injury | Vascular Complications

Austria
Steno Diabetes Center Copenhagen
Novo Nordisk A/S

Unknown

Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria (EmpaSema)

Type 2 Diabetes With Renal Manifestations

Denmark
Cairo University

Recruiting

Efficacy and Safety of Dapagliflozin in Patients With Non-alcoholic Steatohepatitis

Non-alcoholic Steatohepatitis

Egypt
Barnes-Jewish Hospital

Completed

High-Flow Oxygen Therapy Following Tracheostomy

Acute Respiratory Failure

United States
Children's Hospital of Philadelphia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Bone Health in Pediatric Crohn's Disease: A Low Magnitude Mechanical Stimulus Trial

Crohn Disease

United States
AstraZeneca
Bristol-Myers Squibb

Completed

Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 1)

Type 1 Diabetes Mellitus

United States, Austria, Germany, Italy, Spain, United Kingdom, Belgium, Mexico, Israel, Hungary, Canada, Australia, Denmark, Sweden, Romania, France, Finland
AstraZeneca
Astra Zeneca, Bristol-Myers Squibb

Completed

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
Mansoura University

Active, not recruiting

Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients

Lupus Nephritis | SLE | SGLT2 Inhibitors

Egypt
AstraZeneca
Bristol-Myers Squibb

Completed

Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea

Type 2 Diabetes Mellitus | Inadequate Glycaemic Control | High HbA1c Level

Czech Republic, Poland, Spain, Germany, Canada, Slovakia
University Hospital, Basel, Switzerland

Active, not recruiting

Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes (Hypo-PrEA)

Postprandial Hypoglycemia

Switzerland
LM Diagnósticos S.L.
AstraZeneca

Unknown

Effect of Dapagliflozin on Nighttime Blood Pressure in Type 2 Diabetes

Type2 Diabetes

Spain
EMS

Recruiting

Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

Dyslipidemia Associated With Type II Diabetes Mellitus

Brazil
National Medical Research Center for Cardiology...

Recruiting

Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy

Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure With Mid Range Ejection Fraction | Amyloid Cardiomyopathy

Russian Federation
Mayo Clinic
Erchonia Corporation

Active, not recruiting

Low-level Laser and Lifestyle Modifications (LLLT)

Weight Loss | Overweight and Obesity

United States
Tokat Gaziosmanpasa University

Completed

"Effectiveness of Dual-Wavelength Laser Therapy in Third Molar Extraction Pain, Swelling, and Trismus"

Molar, Third | Low-level Laser Therapy

Turkey
University of Gran Rosario

Recruiting

Effects of Low-load Resistance Training With Blood Flow Restriction in Patients With Achilles Tendinopathy

Tendon Injuries | Achilles Tendinopathy | Achilles Tendon Pain

Argentina
Xin Wang

Completed

Construction and Effect Evaluation of the Low Load Blood Flow Restriction Training Program for Lung Cancer Patients Complicated With Sarcopenia During Chemotherapy

Lung Neoplasms | Sarcopenia

China
University of Kansas

Completed

Resistance Training and Blood Flow Restriction

Blood Flow Restriction and Low-Intensity Resistance Training

United States
Cleber Ferraresi
Universidade Federal do Rio Grande do Norte

Completed

Use of Low-level Laser Therapy (808nm) to Muscle Fatigue Resistance

Healthy

Brazil
Assistance Publique - Hôpitaux de Paris

Recruiting

Ivabradine for Heart Rate Control In Septic Shock (IRISS)

Septic Shock

France
Assistance Publique - Hôpitaux de Paris
Iltoo Pharma

Completed

Low-dose IL-2 to the Kinetics of Regulatory T-cell in Healthy Volunteers (HEALTHIL-2)

Healthy Volunteers

France
University of Nove de Julho

Unknown

Photobiomodulation in Individuals With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease
University of Nove de Julho

Unknown

Effect of Low-level Laser Prior to the Induction of Fatigue

Temporomandibular Joint Disorders

Brazil
University of Zurich

Unknown

Low-Level Laser Therapy (LLLT) Treatment for Breast-Feeding Women With Painful Nipple Lesions

Nipple Lesions
Universidade Federal do Rio Grande do Norte

Completed

Laser Therapy on Neuromuscular Performance

Fatigue

Brazil
University of Colorado, Denver

Recruiting

Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients

Vascular Diseases | Diabetes | Kidney Transplant; Complications

United States
University of Oklahoma

Recruiting

Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)

Diabetes Mellitus | Atrial Fibrillation

United States
Andrea Giaccari

Recruiting

Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity (DapaHeart)

Type2 Diabetes Mellitus | Stable Coronary Artery Disease

Italy
University of Pennsylvania
Amgen

Completed

Effect of Dapagliflozin on Submaximal Exercise Tolerance in Heart Failure

HFrEF

United States

Search clinical trials for: Empagliflozin low placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations